secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2026-06-30T21:16:14+00:00
Accession:  0001140361-26-026982
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharma: John Militello resigns as Principal Accounting Officer; Joseph Manhede appointed
--------------------------------------------------------------------------------

- John Militello resigns as VP Finance, Senior Controller, Treasurer and Principal Accounting Officer effective July 7, 2026 to pursue other opportunities.
- Joseph Manhede, age 48, appointed as Principal Accounting Officer effective July 8, 2026; previously Associate VP Corporate Controller since April 2026.
- Manhede previously held senior finance roles at Outlook Therapeutics, Amneal Pharmaceuticals, Unilife, and Celator; began career at Deloitte as Audit Manager.
- No new compensatory arrangements entered into with Manhede in connection with the appointment; no family relationships or reportable transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036126026982/0001140361-26-026982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036126026982/ef20077135_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-026982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer